Similar Posts
These Americans Are Rich – Should We Celebrate?
ByadminAmerican manufacturing has declined precipitously in the past few decades. Companies that were once the source of fabulous wealth for Americans – the U.S. Steel profits that enriched the Carnegie family, the Ford Motor F -1.29% Company profits that enriched its eponymous family – are now struggling to keep up with foreign competitors. Thank God…
Generic Doesn‘t Mean Affordable
ByadminGeneric meds are supposed to be relatively cheap; multiple companies can make the same molecule, leading to price-lowering competition. But that’s not always what happens in the US market. Look at the prices of these generics, in the US vs Canada: We need to take regulatory or legislative steps to reduce the price of generic…
Good and Bad News about Physician Pay
ByadminI’ve got some good news for all of you: there’s no racial disparity in pay among female physicians. African-American physicians in the United States make just as much money as Caucasian women. Unfortunately, this good news is largely a result of dismal news – neither group of women make as much as white male physicians….
6 Tips for Determining if a Doc-in-the-Box Is Right for You
ByadminA friend of mine recently had a very sore throat. She knew how to manage her symptoms–lozenges, warm tea and the like. But she was worried she might have strep and would therefore need antibiotics. That should be a simple question to answer with a quick trip to the primary care clinic. Except that her…
A Business Consultant's Take on Our Research
ByadminHere is a very interesting essay in the Arkansas Business Journal, which ties our research on physician patient conversations into a broader message about the importance of good communication in business. Glad to see our work is having an impact. Considering all of the technical advances and new complexities in marketing today (such as social,…
Is The Golden Era of Pharmaceutical Profits Over?
ByadminFor decades, the pharmaceutical industry has been highly profitable. The recipe for such profits has been pretty simple for most of the last half-century–discover a chemical or molecule that treats a common problem, like hypertension or diabetes or erectile dysfunction, and make billions of dollars while that product is still under patent protection. But of…
